FI974640L - 1,6-disubstituted isochromans for the treatment of migraine - Google Patents
1,6-disubstituted isochromans for the treatment of migraine Download PDFInfo
- Publication number
- FI974640L FI974640L FI974640A FI974640A FI974640L FI 974640 L FI974640 L FI 974640L FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 L FI974640 L FI 974640L
- Authority
- FI
- Finland
- Prior art keywords
- isochromans
- migraine
- disubstituted
- treatment
- disubstituted isochromans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74195P | 1995-06-30 | 1995-06-30 | |
| US1123496P | 1996-02-06 | 1996-02-06 | |
| PCT/US1996/008681 WO1997002259A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI974640A7 FI974640A7 (en) | 1997-12-30 |
| FI974640A0 FI974640A0 (en) | 1997-12-30 |
| FI974640L true FI974640L (en) | 1997-12-30 |
Family
ID=26668092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI974640A FI974640L (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for the treatment of migraine |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0836599A1 (en) |
| JP (1) | JPH11509532A (en) |
| AU (1) | AU6252296A (en) |
| BR (1) | BR9609631A (en) |
| CA (1) | CA2225282A1 (en) |
| CZ (1) | CZ418597A3 (en) |
| FI (1) | FI974640L (en) |
| MX (1) | MX9710260A (en) |
| NO (1) | NO976112L (en) |
| PL (1) | PL324319A1 (en) |
| SK (1) | SK164297A3 (en) |
| WO (1) | WO1997002259A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
| GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
| BRPI0510642A (en) | 2004-05-05 | 2007-11-20 | Hoffmann La Roche | arylsulfonyl benzodioxanes useful for modulating 5-ht6 receptor, 5ht2a receptor or both |
| JP4738418B2 (en) | 2004-12-21 | 2011-08-03 | エフ.ホフマン−ラ ロシュ アーゲー | Chroman derivatives and their use in the treatment of CNS disorders |
| ATE455755T1 (en) | 2004-12-21 | 2010-02-15 | Hoffmann La Roche | TETRALIN AND INDANDE DERIVATIVES AND THEIR APPLICATIONS |
| RU2396264C2 (en) | 2004-12-21 | 2010-08-10 | Ф. Хоффманн-Ля Рош Аг | Chromane derivatives and use thereof as 5-ht receptor ligands |
| ES2314749T3 (en) | 2004-12-21 | 2009-03-16 | F. Hoffmann-La Roche Ag | DERIVATIVES OF TETRALINA AND INDANO AND USES OF THE SAME AS 5-HT ANTAGONISTS. |
| MX2007007481A (en) | 2004-12-21 | 2007-07-20 | Hoffmann La Roche | Tetralin and indane derivatives and uses thereof. |
| ES2359735T3 (en) | 2005-11-03 | 2011-05-26 | F. Hoffmann-La Roche Ag | ARYLSULPHONYL CHROMANES AS 5-HT6 INHIBITORS. |
| WO2007147763A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonyl naphthalene derivatives and uses thereof |
| KR101064001B1 (en) | 2006-06-20 | 2011-09-08 | 에프. 호프만-라 로슈 아게 | Arylsulfonamidyl tetralin derivatives and uses thereof |
| EP2035370A2 (en) | 2006-06-20 | 2009-03-18 | F. Hoffmann-Roche AG | Tetralin and indane derivatives and uses thereof |
| WO2010101299A1 (en) * | 2009-03-05 | 2010-09-10 | 住友化学株式会社 | Method for producing halogen-substituted benzene dimethanol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| JP3773255B2 (en) * | 1993-12-28 | 2006-05-10 | ファルマシア・アンド・アップジョン・カンパニー | Heterocyclic compounds for treating CNS and cardiovascular diseases |
-
1996
- 1996-06-07 JP JP9505135A patent/JPH11509532A/en active Pending
- 1996-06-07 PL PL96324319A patent/PL324319A1/en unknown
- 1996-06-07 MX MX9710260A patent/MX9710260A/en unknown
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 BR BR9609631A patent/BR9609631A/en not_active Application Discontinuation
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/en unknown
- 1996-06-07 FI FI974640A patent/FI974640L/en unknown
- 1996-06-07 SK SK1642-97A patent/SK164297A3/en unknown
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Ceased
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI974640A7 (en) | 1997-12-30 |
| EP0836599A1 (en) | 1998-04-22 |
| NO976112L (en) | 1998-03-02 |
| FI974640A0 (en) | 1997-12-30 |
| BR9609631A (en) | 1999-03-02 |
| PL324319A1 (en) | 1998-05-25 |
| NO976112D0 (en) | 1997-12-29 |
| CA2225282A1 (en) | 1997-01-23 |
| SK164297A3 (en) | 1998-09-09 |
| CZ418597A3 (en) | 1998-06-17 |
| MX9710260A (en) | 1998-03-29 |
| JPH11509532A (en) | 1999-08-24 |
| WO1997002259A1 (en) | 1997-01-23 |
| AU6252296A (en) | 1997-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO981800L (en) | Process for the preparation of 1,1,1,3,3-pentafluoropentane | |
| DK0771789T3 (en) | 1 alpha, 26-dihydroxy-D-homo-vitamin D3 | |
| FI974640A7 (en) | 1,6-disubstituted isochromans for the treatment of migraine | |
| ITTO940748A0 (en) | PROSTHETIC CONDUIT PARTICULARLY FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. | |
| HUP0004085A3 (en) | Novel 3,6-hemiketals from the class of 9a-azalides | |
| FI20011433L (en) | Process for the preparation of 2,5,diamino-4,6-dichloropyrimidine | |
| ITTO960495A0 (en) | PROCEDURE TO INCREASE THE FLOW FOR ELECTROTRANSPORT OF POLIPEP-TIDI. | |
| IT1292552B1 (en) | DEVICE FOR THE APPLICATION OF COATINGS. | |
| DK0815092T3 (en) | Process for the preparation of 1,2-benzisothiazolin-3-ones | |
| EP0811014A4 (en) | NEW BACTERIOCINE, PISCICOLIN 126 | |
| IL113057A0 (en) | Compositions for the treatment of dandruff | |
| ATE220674T1 (en) | 12H-DIBENZO(D,G)(1,3)DIOXOCIN DERIVATIVES | |
| FI964278A7 (en) | Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
| FI930237A7 (en) | Process for the preparation of 4,6-dialkoxypyrimidines | |
| ID16434A (en) | COMPOUNDS OF 1,4-DIHYDROPIRIDINS | |
| DK0783491T3 (en) | Process for the preparation of 3,3,5-trichloro-glutarimide | |
| ES1031096Y (en) | ANTIVANDALICA SHOWER. | |
| EP0579077A3 (en) | 1,3,4-thiadiazinones for the treatment of cardiovascular diseases | |
| FI940088A0 (en) | Regulation / Regulation For the purposes of this Regulation, the provisions of this Regulation shall apply | |
| DK0737068T3 (en) | 2,3-diaryl-1-benzopyrans for the treatment of dermatitis | |
| RU95117268A (en) | MEANS FOR TREATMENT OF ATOPIC DERMATITIS | |
| BR9610047A (en) | 1,3,4-oxadiazolin-2-ones | |
| ITRM940468A0 (en) | "USE OF ESTERURETHANES FOR LS TANNING". | |
| ITTV940061A0 (en) | "PAGE, PARTICULARLY FOR THE PRACTICE OF FENCING". | |
| FI954263A0 (en) | For the purposes of this Regulation, the application was made |